Baidu
map

Stroke:儿童动脉缺血性卒中的炎症生物学标志物

2016-09-26 MedSci MedSci原创

在动脉缺血性卒中的患儿中,在动脉疾病组中,特异性炎症标志物与脑卒中的病因和复发风险有关。针对炎症的干预措施应考虑用于儿科二次卒中预防试验种。

在儿童动脉缺血性卒中的患儿中动脉疾病有很高的复发风险,动脉疾病的发生是一个炎症反应过程。近日,卒中领域权威杂志《Stroke》上发表了用炎症生物学标志物预测儿童动脉缺血性卒中复发的相关研究。

在一个儿童动脉缺血性卒中的国际研究中,研究者选取了3种儿童动脉缺血性卒中最常见病因的病例:明确的动脉疾病性缺血性卒中(n=103),心源性缺血性卒中(n=55)和特发性缺血性卒中(n=78)。通过测量血清超敏C反应蛋白、血清淀粉样蛋白A、髓过氧化物酶和肿瘤坏死因子-α,采用线性回归比较分析和Cox比例风险模型来确定儿童动脉缺血性卒中复发的预测因子。中位卒中年龄为8.2岁(四分位距,3.6–14.3);


在卒中5.5天(间距范围,3–10天)后收集血清标本,在调整后的模型中(包括年龄、梗死体积和样品采集时间),以特发性为参照,心源性(非动脉疾病性)患者组有较高浓度的超敏C反应蛋白和过氧化物酶,而心源性动脉疾病性患者组有较高的血清淀粉样蛋白A,在动脉疾病性(但非心源性)患者组,高C反应蛋白和血清淀粉样蛋白A可预测动脉缺血性卒中的复发。与相对稳定或改善动脉疾病的患儿相比,在随访中有影像学发现动脉疾病有进展的儿童有较高的复发率,并有超敏C反应蛋白和血清淀粉样蛋白A升高的趋势。

在动脉缺血性卒中的患儿中,在动脉疾病组中,特异性炎症标志物与脑卒中的病因和复发风险有关。针对炎症的干预措施应考虑用于儿科二次卒中预防试验种。

原始出处:

Heather J. Fullerton,et al. Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke. Stroke. 2016. http://dx.doi.org/10.1161/STROKEAHA.116.013719

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1806109, encodeId=84f51806109e4, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 06 13:23:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840925, encodeId=90d818409254d, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 22 19:23:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776307, encodeId=b0771e763074b, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Thu Jun 01 13:23:00 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892796, encodeId=80161892e9650, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue May 09 20:23:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933100, encodeId=534d193310009, content=<a href='/topic/show?id=ced969314e4' target=_blank style='color:#2F92EE;'>#生物学标志#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69314, encryptionId=ced969314e4, topicName=生物学标志)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70c362, createdName=jiadan198782, createdTime=Sun Jun 11 21:23:00 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617793, encodeId=ac27161e793c6, content=<a href='/topic/show?id=e88f6930185' target=_blank style='color:#2F92EE;'>#生物学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69301, encryptionId=e88f6930185, topicName=生物学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e44019811593, createdName=12498c32m74暂无昵称, createdTime=Wed Sep 28 09:23:00 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1806109, encodeId=84f51806109e4, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 06 13:23:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840925, encodeId=90d818409254d, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 22 19:23:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776307, encodeId=b0771e763074b, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Thu Jun 01 13:23:00 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892796, encodeId=80161892e9650, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue May 09 20:23:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933100, encodeId=534d193310009, content=<a href='/topic/show?id=ced969314e4' target=_blank style='color:#2F92EE;'>#生物学标志#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69314, encryptionId=ced969314e4, topicName=生物学标志)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70c362, createdName=jiadan198782, createdTime=Sun Jun 11 21:23:00 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617793, encodeId=ac27161e793c6, content=<a href='/topic/show?id=e88f6930185' target=_blank style='color:#2F92EE;'>#生物学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69301, encryptionId=e88f6930185, topicName=生物学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e44019811593, createdName=12498c32m74暂无昵称, createdTime=Wed Sep 28 09:23:00 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1806109, encodeId=84f51806109e4, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 06 13:23:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840925, encodeId=90d818409254d, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 22 19:23:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776307, encodeId=b0771e763074b, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Thu Jun 01 13:23:00 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892796, encodeId=80161892e9650, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue May 09 20:23:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933100, encodeId=534d193310009, content=<a href='/topic/show?id=ced969314e4' target=_blank style='color:#2F92EE;'>#生物学标志#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69314, encryptionId=ced969314e4, topicName=生物学标志)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70c362, createdName=jiadan198782, createdTime=Sun Jun 11 21:23:00 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617793, encodeId=ac27161e793c6, content=<a href='/topic/show?id=e88f6930185' target=_blank style='color:#2F92EE;'>#生物学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69301, encryptionId=e88f6930185, topicName=生物学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e44019811593, createdName=12498c32m74暂无昵称, createdTime=Wed Sep 28 09:23:00 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1806109, encodeId=84f51806109e4, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 06 13:23:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840925, encodeId=90d818409254d, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 22 19:23:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776307, encodeId=b0771e763074b, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Thu Jun 01 13:23:00 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892796, encodeId=80161892e9650, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue May 09 20:23:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933100, encodeId=534d193310009, content=<a href='/topic/show?id=ced969314e4' target=_blank style='color:#2F92EE;'>#生物学标志#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69314, encryptionId=ced969314e4, topicName=生物学标志)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70c362, createdName=jiadan198782, createdTime=Sun Jun 11 21:23:00 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617793, encodeId=ac27161e793c6, content=<a href='/topic/show?id=e88f6930185' target=_blank style='color:#2F92EE;'>#生物学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69301, encryptionId=e88f6930185, topicName=生物学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e44019811593, createdName=12498c32m74暂无昵称, createdTime=Wed Sep 28 09:23:00 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1806109, encodeId=84f51806109e4, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 06 13:23:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840925, encodeId=90d818409254d, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 22 19:23:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776307, encodeId=b0771e763074b, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Thu Jun 01 13:23:00 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892796, encodeId=80161892e9650, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue May 09 20:23:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933100, encodeId=534d193310009, content=<a href='/topic/show?id=ced969314e4' target=_blank style='color:#2F92EE;'>#生物学标志#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69314, encryptionId=ced969314e4, topicName=生物学标志)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70c362, createdName=jiadan198782, createdTime=Sun Jun 11 21:23:00 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617793, encodeId=ac27161e793c6, content=<a href='/topic/show?id=e88f6930185' target=_blank style='color:#2F92EE;'>#生物学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69301, encryptionId=e88f6930185, topicName=生物学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e44019811593, createdName=12498c32m74暂无昵称, createdTime=Wed Sep 28 09:23:00 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1806109, encodeId=84f51806109e4, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 06 13:23:00 CST 2017, time=2017-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840925, encodeId=90d818409254d, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Wed Mar 22 19:23:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776307, encodeId=b0771e763074b, content=<a href='/topic/show?id=539633319e2' target=_blank style='color:#2F92EE;'>#动脉缺血性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33319, encryptionId=539633319e2, topicName=动脉缺血性卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8138921016, createdName=xlysu, createdTime=Thu Jun 01 13:23:00 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1892796, encodeId=80161892e9650, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue May 09 20:23:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933100, encodeId=534d193310009, content=<a href='/topic/show?id=ced969314e4' target=_blank style='color:#2F92EE;'>#生物学标志#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69314, encryptionId=ced969314e4, topicName=生物学标志)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70c362, createdName=jiadan198782, createdTime=Sun Jun 11 21:23:00 CST 2017, time=2017-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617793, encodeId=ac27161e793c6, content=<a href='/topic/show?id=e88f6930185' target=_blank style='color:#2F92EE;'>#生物学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69301, encryptionId=e88f6930185, topicName=生物学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e44019811593, createdName=12498c32m74暂无昵称, createdTime=Wed Sep 28 09:23:00 CST 2016, time=2016-09-28, status=1, ipAttribution=)]

相关资讯

Ann Neurol:英国儿童动脉缺血性卒中预后和复发情况调查

背景:动脉缺血性卒中(AIS)是儿童获得性脑损伤的重要原因。一些有关儿童AIS基于人群的前瞻性研究已经完成。研究者旨在调查人群中儿童AIS事件发生后12个月后的结局。方法:纳入居住在南英格兰(人口599万的孩子)29天到16岁的孩子,这些孩子影像学检查确诊为AIS发生超过1年。应用儿科卒中预后测量量表(PSOM)进行家庭访问确定预后。应用儿童卒中复发和恢复量表(RRQ)评估父母对康复的印象。当家庭

Neurology:紫绀型先天性心脏病的婴幼儿常发生动脉缺血性卒中

目的:为了描述患有心脏病并且发生动脑缺血性卒中(AIS)儿童的心脏疾病谱,及时干预以及患者的预后。方法:收集1993年到2010年间,墨尔本皇家儿童医院患有心脏病并且影像学证实AIS的小于18岁儿童。结果:患有心脏病且影像学诊断为AIS的儿童76名,年龄的中位数为5个月(四分卫间距0-58)。心脏损伤包括紫绀型先天性心脏病(CHD)42名(55%),非紫绀型心脏病24名(29%),心肌疾病/心肌炎

Baidu
map
Baidu
map
Baidu
map